MedPath

Impact of Postoperative Pyuria on Treatment Outcomes After PVP

Conditions
Pyuria
Prostatic Hyperplasia
Registration Number
NCT02241902
Lead Sponsor
DongGuk University
Brief Summary

The aim of this study was to identify serial changes in the incidence of postoperative pyuria after the Photoselective Vaporization of the Prostate (PVP), to determine whether the presence of postoperative pyuria could be correlated with surgical outcomes after surgery and to identify predicting factors that influence on persistent pyuria after the PVP.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
120
Inclusion Criteria
  • men who underwent photoselective vaporization (PVP) using 80 watt potassium-titanyl-phosphate (KTP) laser or 120 watt high-power-system (HPS) laser for benign prostatic hyperplasia refractory to medical treatment
  • sterile urine on urinalysis and urine culture before surgery
  • absence of indwelling urethral catheter before surgery
Exclusion Criteria
  • previous diagnosis of prostate carcinoma or bladder cancer
  • co-existence of urinary stone
  • any antibiotic treatment within 2-weeks before surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the subtotal storage symptoms score of the International Prostate Symptom Score (IPSS)1-week, and 1-, 3- and 6-months after the surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dongguk University ilsan Hospital

🇰🇷

Goyang, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath